ArticlebioRxiv : the preprint server for biology2021

Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors.

Arpan Acharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.